Beranda › Kondisi Pasca-COVID (Long COVID)
Uji klinis Kondisi Pasca-COVID (Long COVID) yang merekrut di AS
118 studi untuk Kondisi Pasca-COVID (Long COVID) merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- New York City, NY15 studi
- Houston, TX13 studi
- Boston, MA13 studi
- Baltimore, MD12 studi
- Chicago, IL11 studi
- Washington, DC10 studi
- San Francisco, CA8 studi
- Atlanta, GA8 studi
- Durham, NC8 studi
- San Diego, CA7 studi
- Hialeah, FL6 studi
- Miami, FL6 studi
- Los Angeles, CA6 studi
- Salt Lake City, UT6 studi
- Pittsburgh, PA6 studi
- Dallas, TX5 studi
- Columbus, OH5 studi
- Mountain View, CA4 studi
- St. Louis, MO4 studi
- Tampa, FL4 studi
- Louisville, KY4 studi
- San Antonio, TX4 studi
- Cincinnati, OH4 studi
- Seattle, WA4 studi
- Birmingham, AL4 studi
- Nashville, TN4 studi
- Austin, TX3 studi
- Sacramento, CA3 studi
- Kendall, FL3 studi
- Omaha, NE3 studi
- Warren, MI3 studi
- Boise, ID3 studi
- Charleston, SC3 studi
- St. Petersburg, FL3 studi
- Homestead, FL3 studi
- The Woodlands, TX3 studi
- New Orleans, LA3 studi
- Portland, OR3 studi
- New Haven, CT3 studi
- Philadelphia, PA3 studi
Berdasarkan negara bagian
- Alabama7 studi
- Arizona4 studi
- California30 studi
- Colorado6 studi
- Connecticut3 studi
- Distrik Columbia4 studi
- Florida13 studi
- Georgia11 studi
- Idaho3 studi
- Illinois13 studi
- Iowa3 studi
- Kansas3 studi
- Kentucky6 studi
- Louisiana7 studi
- Maryland21 studi
- Massachusetts13 studi
- Michigan6 studi
- Minnesota6 studi
- Missouri4 studi
- Nebraska3 studi
- Nevada4 studi
- New Jersey3 studi
- New York18 studi
- North Carolina10 studi
- Ohio11 studi
- Oregon3 studi
- Pennsylvania11 studi
- South Carolina4 studi
- Tennessee8 studi
- Texas23 studi
- Utah7 studi
- Virginia6 studi
- Washington5 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 hingga 64 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07536308Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05624450Exercise in Child Health
Menerima pesertaSukarelawan sehat diterima
Usia 10 hingga 17 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05359991Clinical Outcomes and Pharmacotherapy Effectiveness in the VA Health Care System (COPE-VA)
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06160128SARS-CoV-2 Specific Monoclonal Antibody for Post-COVID-19 Conditions (Long COVID)
Menerima pesertaFase 2
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07021794Long-Term Study of COVID-19 Infection and Long COVID
Menerima pesertaStudi observasional
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07781501Heat thErapy And mobiLity in COVID-19 Survivors
Menerima peserta
Usia 50 hingga 90 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06928116A Study of COVID-19 Vaccine(s) in Children and Adults
Menerima pesertaFase 3Sukarelawan sehat diterima
Usia 5 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07798648A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
Menerima pesertaFase 3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06679140A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07013474Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06631287A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06667700A Study to Examine Anktiva for the Treatment of COVID-19.
Menerima pesertaFase 2
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT07123727A Study of Secutrelvir in Participants With Coronavirus Disease 2019 (COVID-19) Who Are at High Risk for Progression to Severe Disease
Menerima pesertaFase 3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07743580Cross-Sectional Evaluation of Persistence of SARS-CoV-2 Remnants After Recovery From Acute Infection
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 hingga 110 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT06577467Piloting Virtual Reality Environments to Treat PTSD in Healthcare Workers
Menerima pesertaFase awal 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT04887116Viral Infections in Healthy and Immunocompromised Hosts
Menerima pesertaStudi observasionalSukarelawan sehat diterima
6 Months – 120 Years · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT01306084A Study Evaluating MDX2301 in Healthy Adults and Adults at Higher Risk for Severe COVID-19.
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 hingga 64 · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT07445971Natural History of Post-Coronavirus Disease 19 Convalescence at the National Institutes of Health
Menerima pesertaStudi observasional
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT04573062Send-In Sample Collection for Comprehensive Analyses of Innate and Adaptive Immune Responses During Acute COVID-19 and Convalescence
Menerima pesertaStudi observasionalSukarelawan sehat diterima
1 Day – 99 Years · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT04582903Long-Covid-19 Alleviation Through Learning Mindfulness Study
Menerima pesertaSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 31 Agu 2026 · NCT07140094Dime La VerDAD: Verify, Debunk, and Disseminate
Menerima pesertaSukarelawan sehat diterima
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT06417762Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 0 hingga 20 · Semua jenis kelamin · Diperbarui 21 Agu 2026 · NCT04278404Validation of Biomarkers for Long COVID in the LIINC Viral Immunopathogenesis and Persistence Repeat Donor Cohort (VIPER)
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT07770022A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses
Menerima pesertaFase 1/2Sukarelawan sehat diterima
Usia 40 hingga 64 · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT06810934Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.